Cargando…
Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems
Almost all people become infected with herpes viruses, including herpes simplex virus type 1 (HSV-1), during their lifetime. Typically, these viruses persist in a latent form that is resistant to all available antiviral medications. Under certain conditions, such as immunosuppression, the latent for...
Autores principales: | Karpov, Dmitry S., Demidova, Natalia A., Kulagin, Kirill A., Shuvalova, Anastasija I., Kovalev, Maxim A., Simonov, Ruslan A., Karpov, Vadim L., Snezhkina, Anastasiya V., Kudryavtseva, Anna V., Klimova, Regina R., Kushch, Alla A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738314/ https://www.ncbi.nlm.nih.gov/pubmed/36499174 http://dx.doi.org/10.3390/ijms232314847 |
Ejemplares similares
-
CRISPR-CasX is an RNA-dominated enzyme active for human genome editing
por: Liu, Jun-Jie, et al.
Publicado: (2019) -
Leverage of nuclease-deficient CasX for preventing pathological angiogenesis
por: Han, Haote, et al.
Publicado: (2023) -
Preventive Vaccination with Mesenchymal Stem Cells Protects Mice from Lethal Infection Caused by Herpes Simplex Virus 1
por: Klimova, R. R., et al.
Publicado: (2021) -
A catalog of CasX genome editing sites in common model organisms
por: Roberson, Elisha D. O.
Publicado: (2019) -
CRISPR/Cas-Based Approaches to Study Schizophrenia and Other Neurodevelopmental Disorders
por: Kurishev, Artemiy O., et al.
Publicado: (2022)